A detailed history of Aqr Arbitrage LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Aqr Arbitrage LLC holds 387,310 shares of HQL stock, worth $5.46 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
387,310
Previous 384,231 0.8%
Holding current value
$5.46 Million
Previous $5.17 Million 2.09%
% of portfolio
0.32%
Previous 0.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.38 - $14.33 $41,197 - $44,122
3,079 Added 0.8%
387,310 $5.28 Million
Q4 2023

Feb 14, 2024

BUY
$11.35 - $13.6 $1.27 Million - $1.52 Million
111,735 Added 41.0%
384,231 $5.17 Million
Q3 2023

Nov 14, 2023

BUY
$12.38 - $13.69 $1.6 Million - $1.77 Million
128,933 Added 89.81%
272,496 $3.4 Million
Q2 2023

Aug 14, 2023

BUY
$13.13 - $14.17 $654,714 - $706,572
49,864 Added 53.22%
143,563 $1.94 Million
Q1 2023

May 15, 2023

BUY
$13.37 - $14.94 $534,639 - $597,420
39,988 Added 74.45%
93,699 $1.31 Million
Q4 2022

Feb 14, 2023

BUY
$13.55 - $15.23 $591,877 - $665,261
43,681 Added 435.5%
53,711 $763,000
Q3 2022

Nov 14, 2022

BUY
$13.39 - $16.31 $134,301 - $163,589
10,030 New
10,030 $137,000
Q1 2021

May 17, 2021

SELL
$19.31 - $22.07 $1.14 Million - $1.3 Million
-58,795 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$16.8 - $20.21 $182,716 - $219,803
-10,876 Reduced 15.61%
58,795 $1.16 Million
Q3 2020

Nov 16, 2020

BUY
$16.71 - $19.06 $301,999 - $344,471
18,073 Added 35.03%
69,671 $1.23 Million
Q2 2020

Aug 17, 2020

BUY
$14.22 - $18.38 $322,651 - $417,042
22,690 Added 78.49%
51,598 $927,000
Q1 2020

May 15, 2020

BUY
$12.22 - $17.99 $197,035 - $290,070
16,124 Added 126.13%
28,908 $433,000
Q3 2019

Nov 14, 2019

BUY
$15.09 - $17.09 $192,910 - $218,478
12,784 New
12,784 $193,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Aqr Arbitrage LLC Portfolio

Follow Aqr Arbitrage LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Arbitrage LLC with notifications on news.